Pregnancy Point of Care Testing Market: North America Accounts for over 50% Revenue Share

Pregnancy point of care testing market revenues reached US$ 1.2 billion in 2018, according to new study by research firm Fact.MR. Increasing need for rapid and accurate diagnostics with the emergence of advanced technologies is providing an impetus to the ongoing developments in the pregnancy point of care testing market. The study opines that the market will envisage nearly 5% y-o-y in 2019 over 2018, with growing adoption of innovative technologies likely to redefine future trends.
Manufacturers are capitalizing on the increasing ubiquity of smartphones by introducing next-generation pregnancy point of care testing devices that can be connected to smartphone applications, finds Fact.MR. Smartphone-based pregnancy point of care testing products are emerging as a promising alternative to traditional laboratory-based diagnostic testing practices. Leading manufacturers are launching innovating products with smartphone connectivity to cater to the end-users’ demand for easy-to-use at-home pregnancy test kit.
Get Free Sample Report Here:
https://www.factmr.com/connectus/sample?flag=S&rep_id=3560
Table of Content
1. Executive Summary
1.1. Market Outlook
1.2. Market Analysis
1.3. Market Dynamics
1.4. Technology Roadmap
1.5. FMR Analysis and Recommendations
2. Market Overview 
2.1. Market Introduction
2.2. Parent Market Assessment
2.3. Market Definition
2.4. Market Taxonomy
3. Key Market Trends
3.1. Market Trends, By Region
3.2. Macro-economic Indicators
3.3. Key Regulations, By Region
4. Pregnancy Point of Care Testing – Key Inclusions
4.1. Product Comparison, By Pregnancy Test Kits
4.2. Product Comparison, By Fertility Test Kits
4.3. Global Development Indicators, Fertility rate
4.4. Pregnancy Point of Care Testing, Key Insights
4.5. Sensitivity Chart for Pregnancy Test Kits
5. Global Pregnancy Point of Care Testing Market Volume Analysis, 2013–2017 and Forecast 2018–2028 
5.1. Market Volume Projections
5.2. Y-o-Y Growth Analysis and Absolute $ Opportunity
6. Global Pregnancy Point of Care Testing Market - Pricing Analysis
6.1. Pricing Analysis, By Product Type
To be Continue.............
Browse Full Report with ToC Here:  https://www.factmr.com/report/3560/pregnancy-point-of-care-testing-market
North America Accounts for over 50% Revenue Share of the Market
In 2018, the pregnancy point of care testing market in North America was valued at US$ 648 million, according to Fact.MR. Growing prevalence of gynecological and fertility disorders, triggered by changing lifestyle, is leading to the increased adoption of pregnancy point of care testing products across the region.
The Fact.MR study finds that leading manufacturers in North America are adopting advanced technologies for competitive advantages with the launch of more reliable and rapid diagnostics. Despite the ambiguity about the accuracy of commonly available pregnancy point of care testing devices, consumer adoption of these products remains high.
With the adoption of innovative marketing strategies and collaborations with various distributors in the region, manufacturers are gearing up to capitalize on lucrative sales opportunities in the North American pregnancy point of care testing market. Fact.MR opines that, though South Asia is emerging as a high-growth market for pregnancy point of care testing market, North America will continue to remain an important regional market for stakeholders in the foreseeable future.
Abbott Laboratories, Quidel Corporation, Prestige Brands Holdings, Swiss Precision Diagnostics (SPD) GmbH, Church & Dwight Co., Inc., BIOSYNEX SA, EKF Diagnostics Holdings plc, NOW Diagnostics Inc, NG BIOTECH SAS, ulti med Products (Deutschland) GmbH, Procter & Gamble Co., Piramal Enterprises, bioMérieux SA, Atlas Medical UK, and Home Health (UK) Ltd are among the key companies in the pregnancy point of care testing market.